登录查看更多内容

Chemo Mouthpiece

Jeff Kalman

Medical device and implants, International business development expert. Sales & training leader skilled in new product rollouts, growth beyond metrics, change agent, region, country business salvage and team enablement.

发布日期: 2024年5月22日

Introducing the Chemo Mouthpiece, a revolutionary medical device focused on helping patients with the debilitating effects of chemotherapy-induced oral mucositis in adult patients. By cooling the oral mucosa, the Chemo Mouthpiece significantly reduces the severity and incidence of this painful condition, enhancing patient comfort and treatment compliance.

We are actively seeking global distributor partners to expand the reach of this life-changing product.? Are you attending FIME 2024 in Miami.? If so, we want to meet with you and see what can be accomplished in our mission to improve cancer care.

要查看或添加评论，请登录

社区洞察

Market Access

What are the key elements of a successful value proposition for rare disease therapies?
Sample Preparation

How do you reduce sample variability and bias in biomarker studies?
Working with Physicians

You’re struggling to diagnose a complex disease. What tools can help you?
Critical Thinking

How can you construct a sound argument without making assumptions?
Market Access

How can multi-stakeholder collaboration improve rare disease access and affordability?
Experimental Design

How do you choose between different methods of variable selection when dealing with collinearity?
Case Management

What are the best ways to advocate for patients with kidney disease?
Biotechnology

How can you integrate patient perspectives into your clinical trial grant proposal?
Translational Research

How do you recognize and reward the contributions and achievements of stakeholders in translational research?

其他会员也浏览了

Join us on October 19th at 10:30 AM ET for a Mapi Pharma KOL Event

Mapi Pharma 2 年
Reflections from #ASCO2022

Venkat Sethuraman 2 年
The RS Biotherapeutics team is excited to attend CannMed23!

RS BioTherapeutics, Inc. 1 年
Patient at the center – always

Pierre Bourdage 3 年
Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease

Daniel Levine 3 年
?? Paper of the day

Prashant Nasa 1 年
?? Paper of the day

Prashant Nasa 1 年
?? Paper of the day

Prashant Nasa 1 年
How One Rare Disease Organization Used Technology to Provide Greater Patient Insight to FDA

Daniel Levine 6 年
Association of High-Density Lipoprotein Levels with Baseline Coronary Plaque Volumes by Coronary CTA in the EVAPORATE trial

John Nelson MD,FACC,FNLA,FASNC 4 年

社区洞察

其他会员也浏览了

Join us on October 19th at 10:30 AM ET for a Mapi Pharma KOL Event

Reflections from #ASCO2022

The RS Biotherapeutics team is excited to attend CannMed23!

Patient at the center – always

Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease

?? Paper of the day

?? Paper of the day

?? Paper of the day

How One Rare Disease Organization Used Technology to Provide Greater Patient Insight to FDA

Association of High-Density Lipoprotein Levels with Baseline Coronary Plaque Volumes by Coronary CTA in the EVAPORATE trial